Access cutting-edge lung fibrosis treatment through this clinical trial at a research site in Birmingham. Study-provided care at no cost to qualified participants.
Access lung fibrosis specialists in Birmingham at no cost
This study follows strict safety protocols and ethical guidelines
All study-related lung fibrosis treatment provided free
Adults 18 years of age and older or above legal age with lung fibrosis related to systemic autoimmune rheumatic disease can participate in this study. People can only take part if they show no improvement in lung function after standard treatment with immunosuppressant medicine. The main purpose of this study is to find out how a medicine called nerandomilast affects the lungs in people with systemic autoimmune rheumatic disease. Participants are put into 2 groups randomly, which means by chanc
Sponsor: Boehringer Ingelheim
Check if you qualify for this lung fibrosis clinical trial in Birmingham, AL
If you're searching for lung fibrosis treatment options in Birmingham, AL, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Birmingham research site is actively enrolling participants for this clinical trial. You'll receive care from experienced lung fibrosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.